NHS England to stop 'ineffective' treatments

Tonsils removal, breast reduction and snoring surgery will be offered to patients from next year, under plans being drawn up by NHS England.

Officials are to

The treatment will be offered only if it is judged to be of "compelling" benefit and there are no alternatives.

NHS England said the move would affect about 100,000 people every year and estimated £ 200m.

• NHS plans to cut homeopathy treatments
• NHS plan: What we still need to know

NHS England says for most of the 17 procedures under consideration, alternative treatments including physiotherapy, a minor injection or change of diet are likely to be effective.

NHS England national medical director Prof. Stephen Powis said: "If we want the very best clinical care for our patients, we need to stop putting them through the effects and harms outweigh the benefits."

"By reducing unnecessary gold risky procedures for some patients we can get better results while reducing waste and targeting resources to where it is most needed. "

The National Cancer Institute for Health and Care (NICE)

The aim of the patient is to provide a better outcome for the patient. request

These include surgery for snoring, where there is only limited clinical evidence of effectiveness and which poses significant risks to patients.

The othe (19659019) 'Honest conversation'

'Honest conversation'

A more detailed description of the procedure for the treatment of heavy menstrual bleeding and knee arthroscopy 19659009] Breast reduction

NHS England chief executive Simon Stephens

He said: "The NHS is one of the most efficient and effective health services in the world.

"Precisely because the NHS is owned by the public," "

NHS England plans to consult publicly on the proposals 4 July and 28 September, with changes planned to start in 2019-20.

Academy of Medical Royal Colleges Chairwoman Prof. Carrie MacEwen said: "These are evidence based proposals which are subject to clinical scrutiny.

" The Academy of Medical Colleges supports the overall program which will benefit patients, clinicians and the NHS as a whole by reducing harm and targeting those who will benefit most. "